Smoking is a well-documented risk factor for the development of pancreatic adenocarcinoma. Although the most abundant polycyclic aromatic hydrocarbons (PAHs) in cigarette smoke are methylated anthracenes and phenanthrenes, the epigenetic toxicity of these compounds has not been extensively studied. We previously showed that methylanthracenes, which possess a bay-like structure, affect epigenetic events such as an induced release of arachidonic acid, inhibition of gap junctional intercellular communication (GJIC) and induction of mitogen-activated protein kinases in a pluripotent rat liver epithelial stem cell line. Anthracenes with no bay-like structures were inactive. These biological effects are all molecular events associated with the promotional phase of cancer. A human immortalized, nontumorigenic pancreatic ductal epithelial cell line, H6c7, was examined to study the epigenetic toxicity of PAHs related to pancreatic cancer by using scrape-loading dye transfer, immunostaining, RT-PCR and telomerase assay methods. H6c7 cells were GJIC-incompetent and exhibited high telomerase activity when grown in growth factor and hormonesupplemented medium. In the presence of the cAMP elevating drugs (forskolin and IBMX) the cells became GJIC competent and expressed connexins. Telomerase activity was also decreased by cAMP elevating drug treatment. After induction of cAMP, 1-methylanthracene with bay-like structures inhibited GJIC, whereas the 2-methylanthracene lacking a bay-like structure had no effect on GJIC. Telomerase activity remained high in 1-methylanthracene treatment but not with 2-methylanthracene. These results indicate that a prominent component of cigarette smoke, namely methylanthracenes with distinct structural configurations, could be a potential etiological agent contributing to the epigenetic events of pancreatic cancer. ' 2007 Wiley-Liss, Inc.Key words: connexin 36; telomerase; PAH; gap junction Pancreatic cancer is the fourth most common cause of cancerrelated death in the United States. 1,2 Incidence in the developed world parallels the United States, and in undeveloped nations the incidence is lower, which could be due to underreporting. 3 There are no early screening tests and no universally-effective treatment options, making this disease one of the most fatal cancers known, with a 5-year survival rate of less than 5%. 1,3-5 A recent article even suggested no patients are actually ''cured'' of this disease. 6 Although several risk factors, such as diet, have been associated with pancreatic cancer, cigarette smoking is the only unequivocal risk factor that has been identified. 1,7-9 The incidence of pancreatic cancer is 50-90% higher among blacks in the United States than whites. This disparity has been linked primarily to cigarette smoking-and to a lesser extent diabetes-in men, 10 again indicating the significance of tobacco smoke in the incidence of pancreatic cancer.Although cigarette smoke has been identified as one etiological cause of pancreatic cancer, the underlying molecular mechanism ca...